Black Rock Inc. Amphastar Pharmaceuticals, Inc. Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
A detailed history of Black Rock Inc. transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 5,942,524 shares of AMPH stock, worth $265 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
5,942,524
Previous 6,079,042
2.25%
Holding current value
$265 Million
Previous $267 Million
10.95%
% of portfolio
0.01%
Previous 0.01%
Shares
13 transactions
Others Institutions Holding AMPH
# of Institutions
287Shares Held
35.1MCall Options Held
74.3KPut Options Held
22.3K-
Vanguard Group Inc Valley Forge, PA2.71MShares$121 Million0.0% of portfolio
-
Td Asset Management Inc2.14MShares$95.3 Million0.1% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA1.95MShares$86.9 Million0.22% of portfolio
-
Neuberger Berman Group LLC New York, NY1.62MShares$72.1 Million0.06% of portfolio
-
State Street Corp Boston, MA1.53MShares$68.3 Million0.0% of portfolio
About Amphastar Pharmaceuticals, Inc.
- Ticker AMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,015,200
- Market Cap $2.19B
- Description
- Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...